Molecular Pathogenesis of Myeloproliferative Neoplasms: From Molecular Landscape to Therapeutic Implications.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
20 Apr 2022
Historique:
received: 28 03 2022
revised: 15 04 2022
accepted: 19 04 2022
entrez: 14 5 2022
pubmed: 15 5 2022
medline: 18 5 2022
Statut: epublish

Résumé

Despite distinct clinical entities, the myeloproliferative neoplasms (MPN) share morphological similarities, propensity to thrombotic events and leukemic evolution, and a complex molecular pathogenesis. Well-known driver mutations,

Identifiants

pubmed: 35562964
pii: ijms23094573
doi: 10.3390/ijms23094573
pmc: PMC9100530
pii:
doi:

Substances chimiques

CALR protein, human 0
Calreticulin 0
Receptors, Thrombopoietin 0
STAT Transcription Factors 0
MPL protein, human 143641-95-6
Janus Kinase 2 EC 2.7.10.2

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

PLoS Med. 2006 Jul;3(7):e270
pubmed: 16834459
Expert Opin Ther Targets. 2021 Mar;25(3):211-222
pubmed: 33844952
Blood Adv. 2018 Feb 27;2(4):370-380
pubmed: 29467191
Lancet. 2005 Mar 19-25;365(9464):1054-61
pubmed: 15781101
Blood. 2014 Oct 16;124(16):2507-13; quiz 2615
pubmed: 25037629
Blood. 2016 Aug 25;128(8):1121-8
pubmed: 27365426
Blood. 2009 Jun 11;113(24):6182-92
pubmed: 19387008
Blood. 2016 Jul 7;128(1):144-5
pubmed: 27216218
Blood. 2012 Nov 15;120(20):4168-71
pubmed: 22968464
J Leukoc Biol. 2009 Jun;85(6):957-65
pubmed: 19293402
Mol Cell. 2018 Feb 1;69(3):412-425.e6
pubmed: 29395063
Blood. 2010 Jan 7;115(1):38-46
pubmed: 19861679
Nature. 2005 Apr 28;434(7037):1144-8
pubmed: 15793561
Blood Cancer J. 2018 Feb 9;8(2):15
pubmed: 29426921
Leukemia. 2013 Sep;27(9):1861-9
pubmed: 23619563
Blood. 2011 Nov 10;118(19):5227-34
pubmed: 21921040
Blood. 2012 Oct 25;120(17):3397-406
pubmed: 22898602
J Clin Invest. 2019 Mar 4;129(4):1596-1611
pubmed: 30730307
Am J Hematol. 2014 Aug;89(8):E121-4
pubmed: 24753125
Cell Stem Cell. 2013 Jan 3;12(1):37-48
pubmed: 23246483
Am J Hematol. 2018 Mar;93(3):348-355
pubmed: 29164670
Blood. 2021 Nov 25;138(21):2142-2148
pubmed: 33945619
Hematol Oncol Clin North Am. 2021 Apr;35(2):217-236
pubmed: 33641865
Nat Genet. 2011 Dec 04;44(1):23-31
pubmed: 22138693
Cold Spring Harb Perspect Med. 2020 Feb 3;10(2):
pubmed: 31548225
Leukemia. 2014 Jul;28(7):1568-70
pubmed: 24569778
Nat Rev Cancer. 2012 Sep;12(9):599-612
pubmed: 22898539
Blood. 2018 May 3;131(18):2065-2073
pubmed: 29519804
Blood. 2022 May 5;139(18):2797-2815
pubmed: 35286385
Int J Hematol. 2020 Feb;111(2):180-181
pubmed: 31907735
N Engl J Med. 2006 Dec 7;355(23):2452-66
pubmed: 17151367
Am J Hematol. 2019 Jan;94(1):87-92
pubmed: 30390311
J Clin Invest. 2018 Feb 1;128(2):789-804
pubmed: 29355841
Leukemia. 2011 Jul;25(7):1217-9
pubmed: 21537334
Br J Haematol. 2020 Apr;189(2):291-302
pubmed: 31945802
Cells. 2021 Apr 27;10(5):
pubmed: 33925695
Blood Adv. 2016 Nov 30;1(2):105-111
pubmed: 29296803
Ann Hematol. 2020 Jun;99(6):1177-1191
pubmed: 32198525
Leukemia. 2013 Sep;27(9):1826-31
pubmed: 23594705
Blood Adv. 2016 Nov 22;1(1):21-30
pubmed: 29296692
Cancer Cell. 2005 Apr;7(4):387-97
pubmed: 15837627
J Biol Chem. 2006 Jun 30;281(26):17588-98
pubmed: 16606617
Blood. 2019 Jul 11;134(2):199-210
pubmed: 31064751
Blood. 2007 Jul 1;110(1):375-9
pubmed: 17363731
Blood. 2017 Dec 7;130(23):2475-2483
pubmed: 29212804
Br J Haematol. 2018 Nov;183(4):678-681
pubmed: 29171022
Proc Natl Acad Sci U S A. 2014 Dec 16;111(50):E5401-10
pubmed: 25516983
Blood. 2017 Aug 31;130(9):1125-1131
pubmed: 28674026
Blood Adv. 2022 Mar 8;6(5):1585-1597
pubmed: 34521112
Int J Mol Sci. 2021 May 10;22(9):
pubmed: 34068690
N Engl J Med. 2015 Feb 12;372(7):601-612
pubmed: 25671252
Cancer Res. 2010 Jan 15;70(2):447-52
pubmed: 20068184
Blood. 2006 Nov 15;108(10):3472-6
pubmed: 16868251
Leukemia. 2018 Jul;32(7):1631-1642
pubmed: 29654267
Blood. 2016 Aug 11;128(6):839-51
pubmed: 27288519
Leukemia. 2008 Feb;22(2):437-8
pubmed: 17728787
Blood. 2022 Apr 18;:
pubmed: 35436326
Leukemia. 2018 Aug;32(8):1713-1726
pubmed: 29728695
Blood Adv. 2017 Jul 31;1(18):1382-1386
pubmed: 29296779
Blood. 2019 May 16;133(20):2233-2242
pubmed: 30760453
Nature. 2020 Dec;588(7836):157-163
pubmed: 33239784
Blood. 2015 Jan 8;125(2):327-35
pubmed: 25281607
Oncogene. 2012 Mar 8;31(10):1323-33
pubmed: 21785463
JCI Insight. 2018 Nov 15;3(22):
pubmed: 30429377
Haematologica. 2015 Nov;100(11):e438-42
pubmed: 26250577
Blood Cancer J. 2018 Mar 7;8(3):29
pubmed: 29515114
Science. 2009 May 15;324(5929):930-5
pubmed: 19372391
Leukemia. 2010 Oct;24(10):1713-8
pubmed: 20724988
Blood. 2013 May 23;121(21):4388-95
pubmed: 23575445
Cancer Discov. 2016 Apr;6(4):368-81
pubmed: 26951227
Am J Hematol. 2012 Nov;87(11):1010-6
pubmed: 22887079
Leukemia. 2009 Apr;23(4):739-45
pubmed: 19151769
N Engl J Med. 2007 Feb 1;356(5):459-68
pubmed: 17267906
Blood Adv. 2020 Oct 13;4(19):4887-4897
pubmed: 33035330
Cancer Cell. 2012 Aug 14;22(2):180-93
pubmed: 22897849
Blood. 2009 Feb 19;113(8):1778-85
pubmed: 18796624
Am J Hematol. 2014 May;89(5):517-23
pubmed: 24458835
Eur J Haematol. 2014 Apr;92(4):289-97
pubmed: 24372927
N Engl J Med. 2013 Dec 19;369(25):2391-2405
pubmed: 24325359
Blood Rev. 2020 Jul;42:100708
pubmed: 32571583
N Engl J Med. 2018 Oct 11;379(15):1416-1430
pubmed: 30304655
Blood. 2019 Mar 21;133(12):1325-1334
pubmed: 30606702
Blood. 2016 May 19;127(20):2391-405
pubmed: 27069254
Sci Rep. 2016 Jun 29;6:28789
pubmed: 27352931
Blood. 2009 Dec 10;114(25):5201-5
pubmed: 19850737
Blood Cancer J. 2021 Apr 27;11(4):77
pubmed: 33907189
Blood. 2018 Dec 13;132(24):2575-2579
pubmed: 30377195
Blood Adv. 2021 Mar 9;5(5):1442-1451
pubmed: 33666653
Blood. 2009 Feb 19;113(8):1768-77
pubmed: 18845793
Blood. 2020 Jul 2;136(1):61-70
pubmed: 32430500
Blood. 2015 Aug 6;126(6):790-7
pubmed: 26124496
N Engl J Med. 2011 Feb 3;364(5):488-90
pubmed: 21288114
JAMA Oncol. 2018 May 1;4(5):652-659
pubmed: 29522138
Blood Adv. 2020 Apr 28;4(8):1792-1800
pubmed: 32343799
Nature. 2019 Oct;574(7777):273-277
pubmed: 31578525
Leukemia. 2010 Jul;24(7):1302-9
pubmed: 20508616
Leukemia. 2011 Jul;25(7):1219-20
pubmed: 21519343
Blood. 2018 Sep 13;132(11):1095-1105
pubmed: 29954749
Leukemia. 2016 Aug;30(8):1775-8
pubmed: 26987905
Blood. 2016 Mar 10;127(10):1325-35
pubmed: 26668133
Leukemia. 2014 Jul;28(7):1494-500
pubmed: 24496303
Leukemia. 2018 Oct;32(10):2274-2278
pubmed: 29535431
PLoS One. 2013 Sep 16;8(9):e74257
pubmed: 24066127
Cancer Discov. 2015 Mar;5(3):316-31
pubmed: 25572172
J Med Econ. 2020 Jul;23(7):721-727
pubmed: 32159402
J Clin Invest. 2004 Feb;113(4):528-38
pubmed: 14966562
Dis Model Mech. 2011 May;4(3):311-7
pubmed: 21558064
Haematologica. 2009 Apr;94(4):576-80
pubmed: 19229050
PLoS One. 2010 Jun 16;5(6):e11157
pubmed: 20585391
Leukemia. 2020 Feb;34(2):499-509
pubmed: 31462733
Cancers (Basel). 2020 Aug 07;12(8):
pubmed: 32784800
Blood. 2021 Apr 22;137(16):2209-2220
pubmed: 33512474
N Engl J Med. 2013 Dec 19;369(25):2379-90
pubmed: 24325356
Blood. 2016 Jan 21;127(3):325-32
pubmed: 26423830
Hematol Oncol Clin North Am. 2012 Oct;26(5):1053-64
pubmed: 23009937
Mol Cell. 2019 Mar 21;73(6):1292-1305.e8
pubmed: 30765193
J Exp Med. 2016 Jul 25;213(8):1479-96
pubmed: 27401344
Blood. 2014 Apr 3;123(14):2220-8
pubmed: 24478400
Nat Commun. 2020 Jan 7;11(1):73
pubmed: 31911629
Genes Dev. 2019 May 1;33(9-10):482-497
pubmed: 30842218
Blood. 2016 Mar 10;127(10):1219-21
pubmed: 26965919
N Engl J Med. 2014 Dec 25;371(26):2488-98
pubmed: 25426837
Leukemia. 2007 Sep;21(9):1952-9
pubmed: 17625606
Leukemia. 2015 Jan;29(1):249-52
pubmed: 25212275
Cancer Discov. 2020 Nov;10(11):1742-1757
pubmed: 32669286
Leukemia. 2014 Jul;28(7):1407-13
pubmed: 24441292
Nature. 2020 Oct;586(7831):763-768
pubmed: 33057201
J Clin Oncol. 2007 Dec 10;25(35):5630-5
pubmed: 17998545
Leukemia. 2014 Jul;28(7):1472-7
pubmed: 24402162
Blood. 2018 Dec 27;132(26):2707-2721
pubmed: 30366920
Int J Hematol. 2020 Feb;111(2):182-191
pubmed: 31741139

Auteurs

Erika Morsia (E)

Clinica di Ematologia, Ospedali Riuniti di Ancona, Via Conca 71, 60126 Ancona, Italy.

Elena Torre (E)

Clinica di Ematologia, Ospedali Riuniti di Ancona, Via Conca 71, 60126 Ancona, Italy.

Antonella Poloni (A)

Clinica di Ematologia, Ospedali Riuniti di Ancona, Via Conca 71, 60126 Ancona, Italy.

Attilio Olivieri (A)

Clinica di Ematologia, Ospedali Riuniti di Ancona, Via Conca 71, 60126 Ancona, Italy.

Serena Rupoli (S)

Clinica di Ematologia, Ospedali Riuniti di Ancona, Via Conca 71, 60126 Ancona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH